Clinical Trials on Relapsed and Refractory Multiple Myeloma
Total 61151 results
-
Gilead SciencesTerminated
-
OriCell Therapeutics Co., Ltd.RecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed and/or Refractory Multiple MyelomaChina
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
HitGen Inc.TerminatedMultiple Myeloma | Relapsed and Refractory Multiple MyelomaChina
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
PETHEMA FoundationCompletedRelapsed and Refractory Multiple MyelomaSpain
-
Kosin University Gospel HospitalCompletedRelapsed and/or refractorY Multiple MyelomaKorea, Republic of
-
The Pregene (ShenZhen) Biotechnology Company, Ltd.Henan Cancer HospitalUnknownRelapsed and Refractory Multiple MyelomaChina
-
Allife Medical Science and Technology Co., Ltd.UnknownRelapsed and Refractory Multiple Myeloma
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbAbbVieCompletedRelapsed and/or Refractory Multiple MyelomaSpain
-
Piramal Enterprises LimitedCompletedRelapsed and/or Refractory Multiple MyelomaIndia
-
Guangdong Second Provincial General HospitalNot yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Denmark, Spain, Australia, Italy, New Zealand, France, Canada, Germany
-
Genentech, Inc.RecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Australia, Israel
-
Institute of Hematology & Blood Diseases HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.Not yet recruitingRelapsed or Refractory Multiple MyelomaChina
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Japan, Netherlands, Poland, Austria, Portugal, Greece, India
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Italy, Korea, Republic of, Taiwan, China, Germany, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Poland, Israel, Belgium, Greece, Netherlands
-
Wuhan YZY Biopharma Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina, Australia
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Zhujiang HospitalThe Third Affiliated Hospital of Southern Medical University; Sun Yat-Sen Memorial... and other collaboratorsTerminatedRelapsed/Refractory Multiple Myeloma(MM)China
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...UnknownRelapsed or Refractory Multiple MyelomaChina
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
University Hospital TuebingenCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Washington University School of MedicineGenzyme, a Sanofi CompanyCompletedRelapsed Or Refractory Multiple MyelomaUnited States
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Janssen Research & Development, LLCNot yet recruitingRelapsed or Refractory Multiple Myeloma
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Beijing Mabworks Biotech Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple Myeloma
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Xinhua Hospital, Shanghai Jiao Tong University...CARsgen Therapeutics Co., Ltd.Active, not recruitingRefractory or Relapsed Multiple MyelomaChina